151 results on '"Asmussen, K"'
Search Results
2. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
3. PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY:Predictors of achieving stringent remission in patients with established rheumatoid arthritis in clinical remission following a treat-to-target strategy
4. Papilloma-Virus Infektionen bei Frühkarzinomen im Ösophagus- und Ano-Rektum. Drei Beispiele mit Behandlung durch ESD und HPV-Impfung
5. FRI0019 MRI INFLAMMATION, DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ARE MORE EFFECTIVELY REDUCED BY ESCALATION TO BIOLOGICS COMPARED TO CSDMARD-ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY: SECONDARY ANALYSES OF THE IMAGINE-RA TRIAL
6. AB0209 PREDICTORS OF ACHIEVING STRINGENT REMISSION IN PATIENTS WITH ESTABLISHED RHEUMATOID ARTHRITIS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY
7. MAGNETIC RESONANCE IMAGING TENOSYNOVITIS AND OSTEITIS ARE INDEPENDENT PREDICTORS OF RADIOGRAPHIC AND MRI DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION
8. Classification of Disease Manifestations in Primary Sjögren’s Syndrome: Present Status and a New Proposal
9. Revisiting Sjögrenʼs syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK
10. Outcome measures in Sjögrenʼs syndrome
11. PLATELET-ENDOTHELIAL CELL INVOLVEMENT IN THE PATHOGENESIS OF PRIMARY SJÖGREN'S SYNDROME: 68
12. Primary Sjögren's syndrome: the challenge for classification of disease manifestations
13. OP0149 An mri guided treat-to-target strategy in rheumatoid arthritis patients in clinical remission improved mri inflammation but not damage progression – results from the imagine-ra randomised controlled trial
14. FRI0213 The performance of 12 flare definitions including the assessment of spondyloarthritis international society (ASAS)-endorsed definition of clinically important worsening in asdas in patients with axial spondyloarthritis treated with adalimumab for 5 years
15. OP0038 Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in remission in routine care – 2-year outcomes and identification of predictors
16. OP0018 The value of adding mri to a clinical treat-to-target strategy in rheumatoid arthritis patients in clinical remission: clinical and radiographic outcomes from the imagine-ra randomised controlled trial
17. Serious Adverse Events Associated with use Biological Agents for the Treatment of Rheumatic Diseases:Network Meta-Analysis from a National Guideline Panel
18. AB0263 Agreement between Das28, Acr/eular, Sdai, Cdai and Ultrasound Remission in Patients with Rheumatoid Arthritis Receiving Biological Treatment in Routine Care
19. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
20. Circulating Levels of Plasma IL-6, VEGF, YKL-40, and COMP in Spondyloarthritis Patients During anti-TNFa Treatment
21. MRI-Assessment of sacroilac joint inflammation and destruction during anti-TNF-alpha therapy:Results from the Danisk investigator initiated cohort study BIOSPA
22. Changes in plasma IL-6, VEGF, YKL-40 and COMP in Spondyloarthritis Patients During Treatment with TNFa Inhibitors
23. Changes in biomarkers of cartilage and bone turnover in patients with spondyloarthritis treated with TNF-alpha inhibitors:Results from the Danisk investigator initiated cohort study BIOSPA
24. Bowel symptoms in patients with primary Sjögren's syndrome [5]
25. Overview of ASDEX Upgrade Results
26. Spectroscopic Investigations of Tungsten in the EUV Region and the Determination of its Concentration in Tokamaks
27. Investigations of Tungsten in the Central Plasma of ASDEX Upgrade
28. Modelling of Impurity Transport and Radiation for ASDEX Upgrade Discharges
29. Tungsten Erosion and Migration in ASDEX Upgrade
30. Untersuchungen zum Verhalten von Wolfram in Tokamakplasmen
31. Investigations on calibration sources for soft-x-ray plasma spectroscopy and impurity monitors
32. Charge Exchange Fluxes of Ripple Trapped Slowing-Down Ions During L-to-H Transition and ELMs
33. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF inhibitors
34. Analysis of preoperative prognostic factors in first-time surgery for lumbar disc herniation, including Finneson's and modified Spengler's score systems
35. Kalibration eines Röntgenspektrometers zur Bestimmung von Kohlenstoff- und Sauerstoff-Verunreinigungskonzentrationen in Fusionsplasmen
36. Bowel symptoms in patients with primary Sjögren's syndrome
37. Determination of autoantibodies to annexin XI in systemic autoimmune diseases
38. Neutronic values of U-233 and U-236 in the HTGR
39. Fort St. Vrain initial fuel loading and physics tests
40. Low-enrichment and denatured (thorium) fuels for the HTGR: a status report
41. Core design feasibility study for LEU- and MEU/Th-fueled HTGRs
42. Core design study of a very high temperature reactor
43. Overview of ASDEX Upgrade results
44. A sublimation probe for the injection of high-Z impurities into fusion devices
45. SOME LOADING SCHEMES FOR MIXED RECYCLE AND NON-RECYCLE FUEL.
46. Spectroscopic investigations of tungsten in the EUV region and the determination of its concentration in tokamaks
47. Divertor tokamak operation at high densities on ASDEX Upgrade
48. Spectroscopic measurements of tungsten erosion in the ASDEX Upgrade divertor
49. The tungsten experiment in ASDEX Upgrade
50. Quantitative Assessment of Clinical Disease Status in Primary Sjögren's Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.